Vivmark Residential (VMRK) Financial Statements
Historical financial data — 4 statements covering FY2022–FY2025
Vivmark owns a high-quality apartment portfolio with around 184,000 units and is developing another $4.4 billion of residential properties. The company focuses on owning large, high-quality propert...
Vivmark Residential's revenue increased 4.4% year over year, from $2.91B to $3.04B.
Net income decreased 2.8% over the same period, from $1.08B to $1.05B.
Over the 3-year period from FY2022 to FY2025, revenue grew by 15% in total.
Total debt remained relatively stable at $9.19B.
The debt-to-equity ratio stands at 0.75, indicating a moderate leverage profile.
Operating cash flow declined 0.6% to $1.66B.
Vivmark Residential maintains a strong net profit margin of 34.6%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2022 | $2.64B | $1.14B | N/A | N/A | $1.56B | $20.68B | $8.14B | $11.78B |
| FY2023 | $2.77B+5.1% | $928.8M | N/A | N/A | $1.61B | $21.00B | $8.25B | $11.94B |
| FY2024 | $2.91B+5.1% | $1.08B | N/A | N/A | $1.67B | $22.19B | $9.50B | $11.83B |
| FY2025 | $3.04B+4.4% | $1.05B | N/A | N/A | $1.66B | $22.30B | $9.19B | $12.23B |
Balance Sheet Summary (Latest Period)
Vivmark Residential (VMRK) Financial Statements & Revenue History
Vivmark Residential (VMRK) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry trading at $61.17 with a market capitalization of $47. This page provides 4 historical financial statements for Vivmark Residential, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Vivmark Residential reported revenue of $3.0 billion, representing 4.4% year-over-year growth. The net profit margin of 34.6% reflects strong profitability. The debt-to-equity ratio of 0.75 reflects moderate leverage.
VMRK Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Vivmark Residential's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether VMRK is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track VMRK's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Vivmark Residential converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of VMRK's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use VMRK Financial Data
Investors use Vivmark Residential's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare VMRK's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how VMRK's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View VMRK's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Vivmark Residential's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.VMRK trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.